A bill introduced in the Senate would allow Medicare to provide coverage for multi-cancer screening tests once they have been approved and proven to show clinical benefit.
MedPAC s recommendation on Part B add-on pay for costly drugs met strong resistance, but reactions were mixed to a plan to reduce reimbursement for some drugs with as yet unproven clinical benefit.
Genetic counseling for patients with familial colorectal cancer provides significant improvement in feelings of empowerment and mental health, results of the first randomized controlled trial show.